- Home
- BANC vs RCKT Comparison
BANC vs RCKT Comparison
Compare BANC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- RCKT
- Stock Information
- Founded
- BANC 1941
- RCKT 1999
- Country
- BANC United States
- RCKT United States
- Employees
- BANC N/A
- RCKT N/A
- Industry
- BANC Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- RCKT Health Care
- Exchange
- BANC Nasdaq
- RCKT Nasdaq
- Market Cap
- BANC 2.5B
- RCKT 1.9B
- IPO Year
- BANC N/A
- RCKT N/A
- Fundamental
- Price
- BANC $15.81
- RCKT $17.13
- Analyst Decision
- BANC Buy
- RCKT Strong Buy
- Analyst Count
- BANC 11
- RCKT 9
- Target Price
- BANC $17.27
- RCKT $53.22
- AVG Volume (30 Days)
- BANC 2.2M
- RCKT 731.3K
- Earning Date
- BANC 10-22-2024
- RCKT 11-04-2024
- Dividend Yield
- BANC 2.54%
- RCKT N/A
- EPS Growth
- BANC N/A
- RCKT N/A
- EPS
- BANC N/A
- RCKT N/A
- Revenue
- BANC $412,570,000.00
- RCKT N/A
- Revenue This Year
- BANC N/A
- RCKT N/A
- Revenue Next Year
- BANC $9.72
- RCKT $300.20
- P/E Ratio
- BANC N/A
- RCKT N/A
- Revenue Growth
- BANC N/A
- RCKT N/A
- 52 Week Low
- BANC $10.81
- RCKT $15.98
- 52 Week High
- BANC $15.86
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- BANC 65.16
- RCKT 46.41
- Support Level
- BANC $15.20
- RCKT $17.05
- Resistance Level
- BANC $15.69
- RCKT $17.75
- Average True Range (ATR)
- BANC 0.43
- RCKT 0.72
- MACD
- BANC 0.10
- RCKT 0.06
- Stochastic Oscillator
- BANC 97.95
- RCKT 40.23
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.